CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
August 20 2019 - 4:35PM
CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a
leading data-driven company focused on bringing real-world evidence
driven from the point-of-care to the medical cannabis community and
healthcare sector, will be hosting its Q2 2019 earnings call on
Wednesday, August 28, 2019 at 4:30 p.m. Eastern Daylight Time
(EDT).
CB2 will issue a press release and file its earnings on SEDAR at
approximately 4:05 p.m. EDT on Wednesday, August 28, 2019.
The press release will be available at the same time on the
Company’s website at www.cb2insights.com/news and the filed
Financial Statements and accompanying Management Discussion and
Analysis (MD&A) will be available at
https://www.cb2insights.com/financialinfo.
Access via Phone (audio only):
Date: |
Wednesday, August 28, 2019 |
Time: |
4:30 p.m. (EDT) |
US/Canada Toll Free Dial In: |
1-800-319-4610 |
Toronto Local Dial In: |
1-416-915-3239 |
International Dial In: |
1-604-638-5340 |
Call Name: |
CB2 Insights Earnings Call |
A replay of the earnings call will be available on the company’s
website 24 hours after the call takes place.
Submitting Questions:
Those interested in submitting questions for the earnings call
can do so by emailing investors@cb2inisghts.com prior to the start
of the call. CB2 Insights will attempt to answer all
questions submitted, however some questions may not be answered
during the call due to time constraints.
About CB2 Insights
CB2 Insights has a mission to mainstream medical cannabis into
traditional healthcare. We do so by gathering data and
creating objective real-world evidence through our proprietary
software and service brands. Using clinical management and
data collection software at the point-of-care, CB2 Insights and its
group of sub-brands has become a leading force behind bringing
traditional healthcare protocols to the rapidly evolving global
cannabis industry.
For more information please visit www.cb2insights.com.
No securities regulator or exchange has reviewed,
approved, disapproved, or accepts responsibility for the content of
this news release.
Primary Contact:
Dan Thompson
Chief Corporate Officer
1.855.847.4999 ext. 120
For Investor Inquiries:
Sophic Capital
investors@cb2insights.com
CB2 Insights (CSE:CBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
CB2 Insights (CSE:CBII)
Historical Stock Chart
From Sep 2023 to Sep 2024